Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth: A Key Catalyst Accelerating Emphysema Treatment Market Growth in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Emphysema Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for emphysema treatment has been consistently increasing. The market is set to expand from $5.15 billion in 2024 to about $5.4 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. The previous expansion can be credited to factors such as the impact of the smoking epidemic, progress in medical treatments, the implementation of pulmonary rehabilitation programs, enhancement in diagnostic instruments, and an increase in awareness and education.

Emphysema Treatment Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the market for emphysema treatment is projected to experience substantial growth, with an estimated value of "$7.28 billion in 2029", reflecting a compound annual growth rate (CAGR) of 7.7%. Factors contributing to this growth in the projected timeframe include demographic changes such as an aging population, personalized treatment methods, wider accessibility to therapies, a focus on managing symptoms, and team-based healthcare models. Key trends to watch in this period consist of the investigation of gene therapies, the emphasis on patient awareness and power, the implementation of artificial intelligence (AI), improved access to treatment, and the development of long-acting medications.

View the full report here:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Are the Drivers Transforming the Emphysema Treatment Market?
The escalating numbers of chronic obstructive pulmonary disease (COPD) incidents are projected to stimulate the emphysema treatment market's growth. COPD, a group of disorders that impair airflow and cause respiratory difficulties, includes emphysema and chronic bronchitis. Emphysema treatments are critical in curbing the development of COPD, as they concentrate on addressing symptoms, recuperating lung function, and decelerating disease progression. For instance, reports from the Australian Institute of Health and Welfare (AIHW), an Australia-based agency, revealed that approximately 638,000 individuals, or 2.5% of Australia's population, were diagnosed with COPD in 2022. By 2023, COPD accounted for 3.6% of the overall disease burden, making up 50% of all respiratory condition-related burdens. Moreover, in 2022, COPD was the root cause of 7,691 deaths, equating to 29.6 fatalities per 100,000 people and representing 4.0% of all death cases in the nation. Consequently, the increasing prevalence of COPD is driving the growth of the emphysema treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Emphysema Treatment Market?
Leading companies in the emphysema market are focusing on the advancement of minimally invasive procedures to boost their market standing. These procedures pertain to medical interventions or surgical approaches that cause the least disturbance to the body's typical structures. For example, Adena Health System, an American healthcare entity, introduced the Zephyr Valve surgery in January 2022. This procedure represents a minimally invasive alternative to traditional lung volume reduction surgeries for those suffering from lung hyperinflation, prevalent in conditions such as emphysema and COPD. This trailblazing method includes the insertion of tiny, one-way Zephyr Valves into the lung's airways using a bronchoscope. These valves enable trapped air to escape, prevent further accumulation, and allow the healthier portions of the lung to expand, thereby enhancing breathing quality.

Which Segments in the Emphysema Treatment Market Offer the Most Profit Potential?
The emphysema treatment market covered in this report is segmented -

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

Which Firms Dominate the Emphysema Treatment Market by Market Share and Revenue in 2025?
Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Which Regions Offer the Highest Growth Potential in the Emphysema Treatment Market?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.